62
Views
2
CrossRef citations to date
0
Altmetric
PRELIMINARY REPORTS

Intermittent Bolus Dosing of Lidocaine in Emergency Medical Services—An Alternative to Bolus Followed by a Drip

, MD, MPH, , MD, , MD, MS, , MD, MS & , BS
Pages 403-408 | Received 20 Aug 2005, Accepted 17 Jan 2006, Published online: 02 Jul 2009

REFERENCES

  • Bedynek J L, Weinstein K N, Kah R E, Minton P R. Ventricular tachycardia—control by intermittent, intravenous administration of lidocaine hydrochloride. JAMA 1966; 198: 553–5, [INFOTRIEVE], [CSA]
  • Gianelly R, Groeben J O, Spivack A P, Harrison D C. Effect of lidocaine on ventricular arrhythmias in patients with coronary heart disease. N Eng J Med 1967; 277: 1215–9, [CSA]
  • Hartel G, Karhunen P. Lidocaine andventricular arrhythmias. N Eng J Med 1968; 278: 798, [CSA]
  • Lilly L S. Pathophysiology of heart disease. L S Lilly. Williams andWilkins, Media, PA 1993; 272–305
  • Roden D M. Antiarrhythmic drugs. Goodman & Gilman's the Pharmacological Basis of Therapeutics, 9th ed., J G Hardman, L E Limbird. McGraw-Hill, New York, NY 1996
  • DeToledo J C. Lidocaine andseizures. Ther Drug Monit 2000; 22: 320–2, [INFOTRIEVE], [CROSSREF], [CSA]
  • Pfeifer H J, Greenblatt D J, Koch-Weser J. Clinical use andtoxicity of intravenous lidocaine. A report from the Boston Collaborative Drug Surveillance Program. Am Heart J 1976; 92: 168–73, [INFOTRIEVE], [CSA]
  • American Heart Association. 2005 Guidelines for cardiopulmonary resuscitation andcardiovascular Care. Part 7.3: management of symptomatic bradycardia andtachycardia. Circulation 2005; 112: IV-67–77, [CROSSREF], [CSA]
  • Benowitz N. Clinical applications of the pharmacokinetics of lidocaine. Cardiovascular Drug Therapy, K L Melmon. F.A. Davis Co, Philadelphia, PA 1974; 77–101
  • Laurikainen E, Arstila M, Pekkarinen A, Kanto J. Optimum dosage of lidocaine. Int J Clin Pharmacol Ther Toxicol 1985; 23: 16–9, [INFOTRIEVE], [CSA]
  • United States Census Bureau. Census. 2004, Available at http://www.census.gov/. Accessed November 30, 2005
  • P Nolan, T Trujillo, J EM Lidocaine. American Society of Health-System Pharmacists, Bethesda, MD 2001
  • Pieper J, Johnson K. Lidocaine. W E Evans, J J Schenteg, W J Jasko. Applied Therapeutics, Inc, Vancouver, WA 1992
  • Pieper J A, Slaughter R L, Anderson G D, Wyman M G, Lalka D. Lidocaine clinical pharmacokinetics. Drug Intell Clin Pharm 1982; 16: 291–294, [INFOTRIEVE], [CSA]
  • White J, Garrison M. Basic Clinical Pharmacokinetics Handbook. Appliec Therapeutics, Inc, Vancouver, WA 1994; 1–27, 98–107
  • Winter M. Basic Clinical Pharmacokinetics. Applied Therapeutics, Inc, Vancouver, WA 1997

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.